Guidelines for the Use of Recombinant Cytokines in Bioreagents and Cell Culture

The Role of Recombinant Cytokines in Cell Culture

Recombinant cytokines are one of the key raw materials and auxiliary materials in cell culture and biopharmaceutical processes, commonly used in scenarios such as immune cell expansion, mesenchymal stem cell culture, induced differentiation, and organoid construction. Their function is to promote cell proliferation, survival, or functional maturation by activating specific receptor signaling pathways. Different cell types have different requirements for the type, concentration, and combination of cytokines. A common practice is to establish a basal medium based on the cell culture protocol and literature, and then optimize the cytokine supplementation strategy.

In actual production, the sources of cytokines can be divided into eukaryotic expression and prokaryotic expression. Eukaryotic expression products may be closer to natural proteins in terms of post-translational modifications, but cost and yield need to be comprehensively evaluated; prokaryotic expression has a mature process and is suitable for certain cytokines that do not require complex modifications. When purchasing, attention should be paid to quality attributes such as specific activity, purity, and host residuals.

Activity Validation and Batch Consistency

The biological activity of cytokines is their core quality indicator. Conventional activity validation methods include cell proliferation assays, marker expression detection, or signaling pathway phosphorylation analysis. Taking common specifications as an example, product instructions may state the half-maximal effective concentration or unit activity, but the definitions of activity units may differ among suppliers. Parallel comparisons should be performed when changing batches or suppliers.

Batch consistency is particularly important for cell therapy and process development. It is recommended to establish in-house reference standards for key cytokines and periodically perform activity re-verification. The test results for endotoxin, mycoplasma, and exogenous contaminants should meet the quality requirements for the corresponding use. For serum-free culture systems, attention should also be paid to the effects of carrier proteins or stabilizers on cell status.

Storage, Reconstitution, and Usage Precautions

Most recombinant cytokines are supplied as lyophilized powder. During reconstitution, the recommended buffer or medium should be used, and vigorous shaking should be avoided. After reconstitution, it is generally recommended to aliquot and store at low temperature, and to record the reconstitution date and dilution factor. Repeated freeze-thaw cycles may reduce activity, and laboratories should aliquot reasonably based on usage frequency.

Working solutions should be prepared under sterile conditions to avoid microbial contamination. If long-term storage is required, appropriate protective agents can be selected according to the product instructions. For uses related to cell therapy or clinical trials, raw materials compliant with GMP or the corresponding quality grade should be used, and complete procurement and usage records should be retained.

Regulatory Requirements and Industry Expression

The description of cytokine products in the bioreagent industry should be objective, avoiding absolute statements or safety guarantee claims. Product labels generally state "for research use only" or "for further manufacturing use," and the specific use must be consistent with the product registration or filing scope. When used as raw materials for in vitro diagnostics or cell therapy, they must comply with the corresponding quality management standards and regulatory requirements.

With the development of the cell and gene therapy industry, the requirements for the purity, activity, stability, and traceability of recombinant cytokines are continuously increasing. Suppliers should provide detailed quality documents and stability data, and users should establish supplier audit and risk assessment mechanisms. Standardized records and validation are the foundation for ensuring the reproducibility of experiments and production.